Cargando…

Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats

Modification of gut-islet secretions after Roux-En-Y gastric bypass (RYBG) surgery contributes to its metabolic and anti-diabetic benefits. However, there is limited knowledge on tissue-specific hormone distribution post-RYGB surgery and how this compares with best medical treatment (BMT). In the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sridhar, Ananyaa, Khan, Dawood, Abdelaal, Mahmoud, Elliott, Jessie A., Naughton, Violetta, Flatt, Peter R., Le Roux, Carel W., Docherty, Neil G., Moffett, Charlotte R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499270/ https://www.ncbi.nlm.nih.gov/pubmed/36137097 http://dx.doi.org/10.1371/journal.pone.0274788

Ejemplares similares

RYGB surgery has modest effects on intestinal morphology and gut hormone populations in the bypassed biliopancreatic limb but causes reciprocal changes in GLP-2 and PYY in the alimentary limb
por: Sridhar, Ananyaa, et al.
Publicado: (2023)

Zucker Diabetic‐Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model
por: Wang, Andrea N., et al.
Publicado: (2022)

Longitudinal Characterization of the Gut Microbiota in the Diabetic ZDSD Rat Model and Therapeutic Potential of Oligofructose
por: Weninger, Savanna N., et al.
Publicado: (2023)

Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes
por: Peterson, Richard G., et al.
Publicado: (2015)

Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations
por: Sarnobat, D., et al.
Publicado: (2021)

Evidence for Involvement of GIP and GLP-1 Receptors and the Gut-Gonadal Axis in Regulating Female Reproductive Function in Mice
por: Khan, Dawood, et al.
Publicado: (2022)

Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?
por: Martin, William P., et al.
Publicado: (2020)

Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes
por: Katsogiannos, Petros, et al.
Publicado: (2021)

Gastric Inhibitory Polypeptide (GIP) Is Selectively Decreased in the Roux-Limb of Dietary Obese Mice after RYGB Surgery
por: Zhou, Jiaqiang, et al.
Publicado: (2015)

Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
por: Lafferty, Ryan A., et al.
Publicado: (2021)

Binge Eating (BE) and Obesity: Brain Activity and Psychological Measures before and after Roux-En-Y Gastric Bypass (RYGB)
por: Baboumian, Shaunte, et al.
Publicado: (2023)

Age-Related Differences in Response to High-Fat Feeding on Adipose Tissue and Metabolic Profile in ZDSD Rats
por: Davis, Jeremy E., et al.
Publicado: (2013)

Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery
por: Canney, Aoife L, et al.
Publicado: (2019)

Can reversal of RYGB also reverse hypoglycemia?
por: Arora, Ipsa, et al.
Publicado: (2018)

Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells
por: Mohan, Shruti, et al.
Publicado: (2021)

Differential Gene Expression of Subcutaneous Adipose Tissue among Lean, Obese, and after RYGB (Different Timepoints): Systematic Review and Analysis
por: Cruz-García, Elena Marisol, et al.
Publicado: (2022)

The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?
por: Gorman, Dora M., et al.
Publicado: (2016)

ERCP in RYGB-patients: One size fits all?
por: Aabakken, Lars
Publicado: (2020)

The Improvement of Hyperglycemia after RYGB Surgery in Diabetic Rats Is Related to Elevated Hypothalamus GLP-1 Receptor Expression
por: Zynat, Jazyra, et al.
Publicado: (2016)

Sleep, circadian dysrhythmia, obesity and diabetes
por: Sridhar, Gumpeny Ramachandra, et al.
Publicado: (2016)

Beta Cell Physiological Dynamics and Dysfunctional Transitions in Response to Islet Inflammation in Obesity and Diabetes
por: Cerf, Marlon E.
Publicado: (2020)

Dietary Restriction and Medical Therapy Drives PPARα-Regulated Improvements in Early Diabetic Kidney Disease in Male Rats
por: Martin, William P., et al.
Publicado: (2022)

EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
por: Patel, Nisha, et al.
Publicado: (2018)

What Is the Best NGS Enrichment Method for the Molecular Diagnosis of Monogenic Diabetes and Obesity?
por: Philippe, Julien, et al.
Publicado: (2015)

Baicalein Protects against Type 2 Diabetes via Promoting Islet β-Cell Function in Obese Diabetic Mice
por: Fu, Yu, et al.
Publicado: (2014)

Obesity Characteristics Are Poor Predictors of Genetic Mutations Associated with Obesity
por: Al-Humadi, Ahmed W., et al.
Publicado: (2023)

Amylin as a Future Obesity Treatment
por: Dehestani, Babak, et al.
Publicado: (2021)

Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
por: Tanday, Neil, et al.
Publicado: (2021)

Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili, Heshma, et al.
Publicado: (2021)

Glycemic Control after Sleeve Gastrectomy and Roux-En-Y Gastric Bypass in Obese Subjects with Type 2 Diabetes Mellitus
por: Wallenius, Ville, et al.
Publicado: (2017)

Cell-Free DNA Fragments as Biomarkers of Islet β-Cell Death in Obesity and Type 2 Diabetes
por: Arosemena, Marilyn, et al.
Publicado: (2021)

Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice
por: Boland, Brandon B., et al.
Publicado: (2019)

Rotational Transport of Islets: The Best Way for Islets to Get around?
por: Oberhuber, Rupert, et al.
Publicado: (2013)

Obesity indicators that best predict type 2 diabetes in an Indian population: insights from the Kerala Diabetes Prevention Program
por: Kapoor, Nitin, et al.
Publicado: (2020)

A review of the evidence on cardiovascular outcomes from obesity treatment
por: Abdul Wahab, Roshaida, et al.
Publicado: (2023)

‘Diabesity’ down under: overweight and obesity as cultural signifiers for type 2 diabetes mellitus
por: McNaughton, Darlene
Publicado: (2013)

Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different
por: Pucci, A., et al.
Publicado: (2018)

Identifying obesity indicators which best correlate with type 2 diabetes in a Chinese population
por: Xin, Zhong, et al.
Publicado: (2012)

ER stress in rodent islets of Langerhans is concomitant with obesity and β-cell compensation but not with β-cell dysfunction and diabetes
por: Omikorede, O, et al.
Publicado: (2013)

Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice
por: Trivedi, Prerak M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uump2ktnsknpoa22l4vsdoc1b6